Nasdaq · Healthcare

Airsculpt Technologies, Inc. (AIRS)

As-reported financials and recent SEC filings for Airsculpt Technologies, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$151.8M

Net income

$-11.7M

Net margin

-7.7%

Diluted EPS

$-0.19

ROE

-13.3%

P/E (TTM)

—

Market cap

—

Debt / equity

0.6×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$151.8M	$180.3M	$195.9M	$168.8M	$133.3M
Gross profit	—	—	—	—	—
Operating income	$-11.6M	$-1.6M	$9.7M	$-4.5M	$15.8M
Net income	$-11.7M	$-8.0M	$-4.2M	$-14.7M	$10.6M
Diluted EPS	$-0.19	$-0.14	$-0.08	$-0.26	$-0.01

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

SCHEDULE 13G2026-06-01

42026-05-20

42026-05-14

42026-05-14

8-K2026-05-14

42026-05-14

10-Q2026-05-08

8-K2026-05-08

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on AIRS

Search Airsculpt Technologies, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.